NCT07407686
Improving Engagement From Underserved Communities With Prostate Cancer Genetics Services
Not Yet Recruiting · Not specified · Royal Marsden NHS Foundation Trust · registry updated 2026-02-12
Inclusion and exclusion lines below are quoted from ClinicalTrials.gov. No match score is shown, because a score needs a person's age, biomarkers, and treatment dates. Confirm the record with the study team.
Earlier work explored barriers and facilitators to accessing prostate cancer screening, particularly in underserved communities, and provided valuable insights to build upon. This study will explore perspectives on how genetic risk for prostate cancer is explained and understood through in-depth interviews with members of underserved communities. Findings from this work, alongside earlier results, will be used to co-design clear and accessible digital educational resources in collaboration with community members and relevant charities. Participation in cancer screening programmes in the UK varies, with differences linked to socioeconomic status, ethnicity and health literacy. Similar inequalities are seen in access to prostate cancer genetics services, indicating a need for improved engagement. Successful integration of genetics into prostate cancer care requires clear and inclusive information about genetic testing processes, possible outcomes and interpretation of results. Currently, there are limited resources explaining genetic risk for prostate cancer in an accessible way....
Inclusion
- Men and people with prostates age 18 and above
- Those who belong to the three underserved groups; Black African and Black Caribbean Ancestry, transgender and non-binary people with a prostate and those with reduced access to healthcare
- We allow intersectionality within reason and will narratively describe any instances of these in the writeup of findings
- Those who are able to freely consent to inclusion
- Individuals with and without a lived experience of prostate cancer
Exclusion
- To avoid exhaustion, we will only allow participation in two interview or focus groups per individual for the entirety of the study
- Those without capacity to consent to interview (capacity is assumed unless there is good reason to believe otherwise)